Source: Silicon Valley Daily

Schrodinger: Schrdinger to Present at the Morgan Stanley 18th Annual Global Healthcare Conference

NEW YORK--(BUSINESS WIRE)--Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced that members of the management team will participate in a fi...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Ramy Farid's photo - President & CEO of Schrodinger

President & CEO

Ramy Farid

CEO Approval Rating


Schrodinger develops a chemical simulation software that offers drug design and molecular modeling solutions for pharmaceutical and biotechnology companies. Read more